Stockscreener 앱 받기
1.36
11.48%
0.14
시장 영업 전:
1.36
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions Reports Strong Q3 2025 Results - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - Yahoo Finance
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - ADVFN
Intelligent Bio Solutions (INBS) Sees Revenue Dip but Focuses on Strategic Growth | INBS Stock News - GuruFocus
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Res - GuruFocus
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% - Yahoo Finance
Intelligent Bio Solutions (NASDAQ: INBS) Is ‘One to Watch’ - The Globe and Mail
Intelligent Bio Solutions (INBS) Expands Global Presence with Ne - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multiling - GuruFocus
Intelligent Bio Solutions (INBS) Expands Global Presence with New Websites | INBS Stock News - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - The Manila Times
Intelligent Bio Solutions Targets $1.1B Market with Global Drug Testing Expansion in Arabic, Spanish Markets - Stock Titan
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Average Rating of “Hold” by Analysts - American Banking and Market News
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Dru - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
XTX Topco Ltd Buys New Position in Credit Acceptance Co. (NASDAQ:CACC) - American Banking and Market News
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Time to Buy? - Defense World
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - MSN
U.S. Patent Granted to Intelligent Bio Solutions for Drug Screening Tech - Medical Product Outsourcing
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - The Manila Times
Major Market Expansion: Drug Screening Tech Now Reaches 450 Million Arabic Speakers - Stock Titan
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - The Manila Times
Game-Changing Drug Testing Technology: Non-Invasive Solution Poised for Major US Launch - Stock Titan
MasterCard : Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - MarketScreener
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - The Manila Times
Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra - MarketScreener
Major Expansion: Intelligent Bio Solutions Captures $448M Spanish Drug Testing Market with 1,000 Monthly Orders - Stock Titan
US patent granted for INBS’ fingerprint drug screening technology - Yahoo
Intelligent Bio Solutions secures new U.S. patent By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening - TipRanks
Intelligent Bio Solutions secures new U.S. patent - Investing.com
Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge - Marketscreener.com
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - Stock Titan
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology - Benzinga
Intelligent Bio Solutions On Track For 2025 U.S. Launch Of FDA-Cleared Fingerprint Drug Test - Nasdaq
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - The Manila Times
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch - TradingView
Revolutionary Drug Screening System Achieves 94% Accuracy in FDA Submission Data - Stock Titan
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch - Yahoo
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval - TipRanks
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 - The Globe and Mail
Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology - Marketscreener.com
Intelligent Bio Solutions Inc. Announces Anticipated Sixth Patent for Lateral Flow Technology in Drug Testing Solution - Nasdaq
Intelligent Bio Solutions set to secure new US patent - Investing.com
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - The Manila Times
Revolutionary Fingerprint Drug Test Patent Strengthens Intelligent Bio Solutions Market Position - Stock Titan
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
0.74%
0.94%
자본화:
|
볼륨(24시간):